Responses

Download PDFPDF

Successful treatment with interferon alfa in infiltrating angiolipoma: a case presenting with Kasabach-Merritt syndrome
Free
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Author's reply
    • Suna Emir, Pediatric Oncologist
    • Other Contributors:
      • Canan Akyüz.

    Dear Editor

    We thank Dr Biban for his comments on our article.[1] We share his concerns that our case has some interesting and unique points. As he/she stated that our case was the first reported case of a Kasabach-Merrit syndrome (KSM) associated with a lipomatous tumor. Her severe findings due to KSM and as well as her progressively enlarging mass on the shoulder were dramatically responded to interferon therapy.[...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Kasabach-Merritt syndrome and interferon alpha: still a controversial issue.

    Dear Editor

    We read with interest the paper by Akyuz and colleagues,[1] which described a 2 year old patient with a Kasabach-Merritt syndrome (KMS) secondary to an infiltrating angiolipoma, who was successfully treated with interferon alpha 2a (IFN-alpha).

    Although the case presents some points of interest, such as the previously unreported association of a KMS with a lipomatous tumor and the potential effec...

    Show More
    Conflict of Interest:
    None declared.